Thackray Helen M.
SEC insider (Form 3/4/5 filer). CIK 0001589725. Chief R&D Officer at BIOCRYST PHARMACEUTICALS INC (BCRX). 4 reported Form 4/5 transactions since Sep 2024; latest on Mar 31, 2025. Located in DURHAM, NC.
Companies Thackray Helen M. has filed insider reports for
- BIOCRYST PHARMACEUTICALS INC (BCRX): Officer, Chief R&D Officer
Thackray Helen M.
CIK: 0001589725
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (25.0%)
Compensation grants
Other (G, F, J, C, D, …)3 (75.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BCRX
BIOCRYST PHARMACEUTICALS INC
Officer
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Mar 31, 2025BCRX
BIOCRYST PHARMACEUTICALS INC
Tax PaymentDirect7.5K shares at avg. $7.50$56K - Dec 19, 2024BCRX
BIOCRYST PHARMACEUTICALS INC
AwardDirect126K shares- - Dec 19, 2024BCRX
BIOCRYST PHARMACEUTICALS INC
Tax PaymentDirect6.1K shares at avg. $7.39$45K - Dec 14, 2024BCRX
BIOCRYST PHARMACEUTICALS INC
Tax PaymentDirect7.2K shares at avg. $7.53$54K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 31, 2025 | BCRX BIOCRYST PHARMACEUTICALS INC | Tax Payment | 7,525 | $7.50 | $56,438 | Direct |
| Dec 19, 2024 | BCRX BIOCRYST PHARMACEUTICALS INC | Award | 125,950 | - | $0 | Direct |
| Dec 19, 2024 | BCRX BIOCRYST PHARMACEUTICALS INC | Tax Payment | 6,096 | $7.39 | $45,049 | Direct |
| Dec 14, 2024 | BCRX BIOCRYST PHARMACEUTICALS INC | Tax Payment | 7,150 | $7.53 | $53,840 | Direct |
1-4 of 4 transactions